Corticosteroids, central serous chorioretinopathy, and neurocysticercosis

Journal article

Open access

Peer reviewed

Esther M Bowie, James C Folk and Charles H Barnes

Archives of ophthalmology (1960), Vol.122(2), pp.281-283

02/2004

DOI: 10.1001/archopht.122.2.281

PMID: 14769610

Files and links (1)

url

https://doi.org/10.1001/archopht.122.2.281View

Published (Version of record) Open Access

no abstract | report of a case

Magnetic Resonance Imaging

Prednisolone - adverse effects

Ventriculoperitoneal Shunt

Humans

Male

Neurocysticercosis - complications

Neurocysticercosis - diagnosis

Adult

Drug Therapy, Combination

Glucocorticoids - adverse effects

Fluorescein Angiography

Albendazole - therapeutic use

Retinal Diseases - diagnosis

Retinal Diseases - complications

Anticonvulsants - therapeutic use

Combined Modality Therapy

Triamcinolone Acetonide - adverse effects

Visual Acuity

Phenytoin - therapeutic use

Neurocysticercosis - drug therapy

Retinal Diseases - drug therapy

Antiprotozoal Agents - therapeutic use

Body Fluids

Exudates and Transudates

Vision Disorders - etiology

Title: Subtitle: Corticosteroids, central serous chorioretinopathy, and neurocysticercosis
Creators: Esther M Bowie
James C Folk
Charles H Barnes
Resource Type: Journal article
Publication Details: Archives of ophthalmology (1960), Vol.122(2), pp.281-283
DOI: 10.1001/archopht.122.2.281
PMID: 14769610
NLM abbreviation: Arch Ophthalmol
ISSN: 0003-9950
eISSN: 1538-3601
Publisher: American Medical Association; United States
Language: English
Date published: 02/2004
Academic Unit: Ophthalmology and Visual Sciences
Record Identifier: 9983979952202771

18 Record Views